Sharanappa Basappa Rajur

Title: Sharanappa Basappa Rajur: Innovator in Therapeutic Agent Detection

Introduction

Sharanappa Basappa Rajur is a notable inventor based in Andover, MA (US). He has made significant contributions to the field of therapeutic agent detection, particularly in relation to nucleoside reverse transcriptase inhibitors (NRTIs). His innovative work has implications for monitoring adherence to important medical treatments.

Latest Patents

Sharanappa holds a patent for "Reagents, methods, and systems for detecting therapeutic agents to monitor adherence to nucleoside reverse transcriptase inhibitor metabolites." This invention provides novel compounds, reagents, systems, and methods for detecting a metabolite related to an NRTI in a biological sample. The technology is designed to monitor adherence to pre-exposure prophylaxis, utilizing reagents that comprise NRTI derivatives, analogs, and conjugates, along with antibodies directed to these compounds. These advancements are particularly useful for antibody-based methods, such as lateral flow immunoassays and other point-of-care devices.

Career Highlights

Sharanappa is currently employed at OraSure Technologies, Inc., where he continues to develop innovative solutions in the healthcare sector. His work focuses on enhancing the detection and monitoring of therapeutic agents, which is crucial for patient adherence to treatment regimens.

Collaborations

Sharanappa collaborates with talented professionals in his field, including Giffin Daughtridge and Keith Kardos. These partnerships contribute to the advancement of his research and the successful implementation of his inventions.

Conclusion

Sharanappa Basappa Rajur is a distinguished inventor whose work in therapeutic agent detection is paving the way for improved patient care and adherence monitoring. His contributions to the field are invaluable and highlight the importance of innovation in healthcare.